Alamar Biosciences, Inc. (ALMR)
NASDAQ: ALMR · Real-Time Price · USD
26.49
+2.66 (11.16%)
Jun 25, 2026, 10:38 AM EDT - Market open
Alamar Biosciences Earnings Call Transcripts
Fiscal Year 2026
-
A precision proteomics platform launched in 2024 has achieved rapid adoption, especially in neurology and Alzheimer's research, with strong revenue growth and industry-leading sales efficiency. Strategic priorities include expanding content, commercial reach, and moving toward clinical diagnostics, with FDA submission expected next year.